{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:46:15Z","timestamp":1773279975574,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,3,28]],"date-time":"2008-03-28T00:00:00Z","timestamp":1206662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s11255-008-9373-4","type":"journal-article","created":{"date-parts":[[2008,3,27]],"date-time":"2008-03-27T11:51:25Z","timestamp":1206618685000},"page":"443-451","source":"Crossref","is-referenced-by-count":58,"title":["Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate"],"prefix":"10.1007","volume":"40","author":[{"given":"Melvin R.","family":"Hayden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Sowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,28]]},"reference":[{"key":"9373_CR1","doi-asserted-by":"crossref","unstructured":"Virchow R (1855) Kalk Metastasen. Arch Pathol Anato 8:103\u2013113","DOI":"10.1007\/BF01935316"},{"key":"9373_CR2","doi-asserted-by":"crossref","unstructured":"Virchow R (1863) Cellular pathology: as based upon physiological and pathological histology (trans: Chance F (1971)). An unabridged and unaltered republication of the English translation originally published in Dover, New York, pp 404\u2013408","DOI":"10.5962\/bhl.title.32770"},{"key":"9373_CR3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5414\/CNP63146","volume":"63","author":"CM Shanahan","year":"2005","unstructured":"Shanahan CM (2005) Mechanisms of vascular calcification in renal disease. Clin Nephrol 63:146\u2013157","journal-title":"Clin Nephrol"},{"key":"9373_CR4","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112\u2013S119","journal-title":"Am J Kidney Dis"},{"key":"9373_CR5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2796.2006.01679.x","volume":"260","author":"KP Klausen","year":"2006","unstructured":"Klausen KP, Scharling H, Jensen JS (2006) Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. J Intern Med 260:231\u2013237","journal-title":"J Intern Med"},{"key":"9373_CR6","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","volume":"112","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Sacks F, Pfeffer M et\u00a0al (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112:2627\u20132633","journal-title":"Circulation"},{"issue":"2","key":"9373_CR7","first-page":"205","volume":"17","author":"PA McCullough","year":"2004","unstructured":"McCullough PA, Sandberg KR, Dumler F, Yanez JE (2004) Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review. J Nephrol 17(2):205\u2013215","journal-title":"J Nephrol"},{"key":"9373_CR8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/j.ajkd.2004.11.011","volume":"45","author":"MC Wang","year":"2005","unstructured":"Wang MC, Tsai WC, Chen JY, Huang JJ (2005) Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis 45:494\u2013501","journal-title":"Am J Kidney Dis"},{"key":"9373_CR9","doi-asserted-by":"crossref","unstructured":"Schoppet M, Shroff RC, Hofbauer LC, Shanahan CM (2007) Exploring the biology of vascular calcification in chronic kidney disease: what\u2019s circulating? Kidney Int (Epub ahead of print)","DOI":"10.1038\/sj.ki.5002696"},{"key":"9373_CR10","volume-title":"Calciphylaxis","author":"H Selye","year":"1962","unstructured":"Selye H (1962) Calciphylaxis. The University of Chicago Press, Chicago"},{"issue":"5658","key":"9373_CR11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.2.5658.670","volume":"2","author":"JK Rees","year":"1969","unstructured":"Rees JK, Coles GA (1969) Calciphylaxis in man. Br Med J 2(5658):670\u2013672","journal-title":"Br Med J"},{"issue":"11","key":"9373_CR12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/archinte.1976.03630110043012","volume":"136","author":"RM Gipstein","year":"1976","unstructured":"Gipstein RM, Coburn JW, Adams DA, Lee DB, Parsa KP, Sellers A, Suki WN, Massry SG (1976) Calciphylaxis in man. A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure. Arch Intern Med 136(11):1273\u20131280","journal-title":"Arch Intern Med"},{"issue":"3","key":"9373_CR13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/ajkd.1998.v32.pm9740153","volume":"32","author":"T Coates","year":"1998","unstructured":"Coates T, Kirkland GS, Dymock RB, Murphy BF, Brealey JK, Mathew TH, Disney AP (1998) Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis 32(3):384\u2013391","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"9373_CR14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1525-139X.2002.00052.x","volume":"15","author":"WA Wilmer","year":"2002","unstructured":"Wilmer WA, Magro CM (2002) Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial 15(3):172\u2013186","journal-title":"Semin Dial"},{"issue":"1","key":"9373_CR15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-2840-4-4","volume":"4","author":"MR Hayden","year":"2005","unstructured":"Hayden MR, Tyagi SC, Kolb L, Sowers JR, Khanna R (2005) Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovasc Diabetol 4(1):4","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"9373_CR16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5414\/CNP59463","volume":"59","author":"BR Don","year":"2003","unstructured":"Don BR, Chin AI (2003) A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies. Clin Nephrol 59(6):463\u2013470","journal-title":"Clin Nephrol"},{"issue":"2","key":"9373_CR17","first-page":"63","volume":"23","author":"H Yatzidis","year":"1985","unstructured":"Yatzidis H (1985) Successful sodium thiosulphate treatment for recurrent calcium urolithiasis. Clin Nephrol 23(2):63\u201367","journal-title":"Clin Nephrol"},{"issue":"4","key":"9373_CR18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/089686088700700411","volume":"7","author":"H Yatzidis","year":"1987","unstructured":"Yatzidis H, Agroyannis B (1987) Sodium thiosulfate treatment of soft-tissue calcifications in patients with end-stage renal disease. Perit Dial Int 7(4):250\u2013252","journal-title":"Perit Dial Int"},{"issue":"6","key":"9373_CR19","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.ajkd.2004.03.018","volume":"43","author":"JS Cicone","year":"2004","unstructured":"Cicone JS, Petronis JB, Embert CD, Spector DA (2004) Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 43(6):1104\u20131108","journal-title":"Am J Kidney Dis"},{"key":"9373_CR20","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/ndt\/gfh825","volume":"20","author":"G Guerra","year":"2005","unstructured":"Guerra G, Shah RC, Ross EA (2005) Rapid resolution of calciphylaxis with intravenous sodium thiosulphate and continuous venovenous haemofiltration using low calcium replacement fluid: case report. Nephrol Dial Transplant 20:1260\u20131262","journal-title":"Nephrol Dial Transplant"},{"key":"9373_CR21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1525-139X.2005.00082.x","volume":"18","author":"M Brucculeri","year":"2005","unstructured":"Brucculeri M, Cheigh J, Bauer G, Serur D (2005) Long-term intravenous sodium thiosulphate in the treatment of a patient with calciphylaxis. Semin Dial 18:431\u2013434","journal-title":"Semin Dial"},{"issue":"6","key":"9373_CR22","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2215\/CJN.01520506","volume":"1","author":"CE Araya","year":"2006","unstructured":"Araya CE, Fennell RS, Neiberger RE, Dharnidharka VR (2006) Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol 1(6):1161\u20131166","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"9373_CR23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.0197-3118.2006.05459.x","volume":"1","author":"MR Hayden","year":"2006","unstructured":"Hayden MR, Kolb LG, Khanna R (2006) Calciphylaxis and the cardiometabolic syndrome. J Cardiometab Syndr 1(1):76\u201379","journal-title":"J Cardiometab Syndr"},{"key":"9373_CR24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000092290","volume":"212","author":"M Meissner","year":"2006","unstructured":"Meissner M, Bauer R, Beier C, Betz C, Wolter M, Kaufmann R, Gille J (2006) Sodium thiosulphate as a promising therapeutic option to treat calciphylaxis. Dermatology 212:373\u2013376","journal-title":"Dermatology"},{"key":"9373_CR25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5414\/CNP66140","volume":"66","author":"K Tokashiki","year":"2006","unstructured":"Tokashiki K, Ishida A, Kouchi M et\u00a0al (2006) Successful management of critical limb ischemia with intravenous sodium thiosulphate in a chronic hemodialysis patient. Clin Nephrol 66:140\u2013143","journal-title":"Clin Nephrol"},{"key":"9373_CR26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/08860220600583781","volume":"28","author":"D Mataic","year":"2006","unstructured":"Mataic D, Bastani B (2006) Intraperitoneal sodium thiosulphate for the treatment of calciphylaxis. Ren Fail 28:361\u2013363","journal-title":"Ren Fail"},{"issue":"2","key":"9373_CR27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/archderm.143.2.269","volume":"143","author":"BL Baker","year":"2007","unstructured":"Baker BL, Fitzgibbons CA, Buescher LS (2007) Calciphylaxis responding to sodium thiosulfate therapy. Arch Dermatol 143(2):269\u2013270","journal-title":"Arch Dermatol"},{"key":"9373_CR28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/archderm.143.10.1336","volume":"143","author":"F Ackermann","year":"2007","unstructured":"Ackermann F, Levy A, Daugas E, Schartz N, Riaux A, Derancourt C, Urena P, Lebb\u00e9 C (2007) Sodium thiosulfate as first-line treatment for calciphylaxis. Arch Dermatol 143(10):1336\u20131337","journal-title":"Arch Dermatol"},{"issue":"1","key":"9373_CR29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1440-0960.2007.00416.x","volume":"49","author":"K Subramaniam","year":"2008","unstructured":"Subramaniam K, Wallace H, Sinniah R, Saker B (2008) Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulfate. Australas J Dermatol 49(1):30\u201334","journal-title":"Australas J Dermatol"},{"key":"9373_CR30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1124\/jpet.105.091595","volume":"316","author":"E Distrutti","year":"2005","unstructured":"Distrutti E, Sediari L, Mencarelli A et\u00a0al (2005) Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. J Pharmacol Exp Ther 316:325\u2013335","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"9373_CR31","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1096\/fj.06-6270fje","volume":"20","author":"RC Zanardo","year":"2006","unstructured":"Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL (2006) Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20(12):2118\u20132120","journal-title":"FASEB J"},{"issue":"2","key":"9373_CR32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2215\/CJN.03250906","volume":"2","author":"P Yerram","year":"2007","unstructured":"Yerram P, Saab G, Karuparthi PR, Hayden MR, Khanna R (2007) Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure-role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. Clin J Am Soc Nephrol 2(2):258\u2013263","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"9373_CR33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1742-1241.2006.01259.x","volume":"61","author":"S Al-Khoury","year":"2007","unstructured":"Al-Khoury S, Afzali B, Shah N, Thomas S, Gusbeth-Tatomir P, Goldsmith D, Covic A (2007) Diabetes, kidney disease and anaemia: time to tackle a troublesome triad? Int J Clin Pract 61(2):281\u2013289","journal-title":"Int J Clin Pract"},{"issue":"2","key":"9373_CR34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1525-139X.2007.00265.x","volume":"20","author":"A Covic","year":"2007","unstructured":"Covic A, Gusbeth-Tatomir P, Goldsmith DJ (2007) Vascular calcification\u2014a new window on the cardiovascular system: role of agents used to manipulate skeletal integrity. Semin Dial 20(2):158\u2013169","journal-title":"Semin Dial"},{"issue":"2","key":"9373_CR35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1525-139X.2007.00263.x","volume":"20","author":"NM Rogers","year":"2007","unstructured":"Rogers NM, Teubner DJ, Coates PT (2007) Calcific uremic arteriolopathy: advances in pathogenesis and treatment. Semin Dial 20(2):150\u2013157","journal-title":"Semin Dial"},{"key":"9373_CR36","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/ndt\/15.10.1691","volume":"15","author":"MK Phanish","year":"2000","unstructured":"Phanish MK, Kallarackal G, Ravanan R et\u00a0al (2000) Tumoral calcinosis associated with pyrexia and systemic inflammatory response in a haemodialysis patient: successful treatment using intravenous pamidronate. Nephrol Dial Transplant 15:1691\u20131693","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"9373_CR37","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/ndt\/gfh305","volume":"19","author":"P Monney","year":"2004","unstructured":"Monney P, Nguyen QV, Perroud H, Descombes E (2004) Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrol Dial Transplant 19(8):2130\u20132132","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"9373_CR38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/089686080602600620","volume":"26","author":"CG Musso","year":"2006","unstructured":"Musso CG, Enz PA, Guelman R, Mombelli C, Imperiali N, Plantalech L, Kowalczuk A, Galimberti R, Algranati LS (2006) Non-ulcerating calcific uremic arteriolopathy skin lesion treated successfully with intravenous ibandronate. Perit Dial Int 26(6):717\u2013718","journal-title":"Perit Dial Int"},{"key":"9373_CR39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jbmr.5650020209","volume":"2","author":"MG Cecchini","year":"1987","unstructured":"Cecchini MG, Felix R, Fleisch H, Cooper PH (1987) Effects of bisphosphonates on proliferation and viability of mouse bone marrow derived macrophages. J Bone Miner Res 2:135\u2013142","journal-title":"J Bone Miner Res"},{"key":"9373_CR40","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1023\/A:1016281608773","volume":"12","author":"N Pennanen","year":"1995","unstructured":"Pennanen N, Lapinjoki S, Urtti A, Monkkonen J (1995) Effect of liposomal and free bisphosphonates on IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in\u00a0vitro. Pharm Res 12:916\u2013922","journal-title":"Pharm Res"},{"key":"9373_CR41","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archderm.140.9.1045","volume":"140","author":"LD Sewell","year":"2004","unstructured":"Sewell LD, Weenig RH, Davis MDP, McEvoy MT, Pittelkow MR (2004) Low dose tissue plasminogen activator for calciphylaxis. Arch Dermatol 140:1043\u20131048","journal-title":"Arch Dermatol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-008-9373-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-008-9373-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-008-9373-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T09:13:24Z","timestamp":1684314804000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-008-9373-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,28]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["9373"],"URL":"https:\/\/doi.org\/10.1007\/s11255-008-9373-4","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,28]]}}}